(MMI) Marcus & Millichap - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5663241090
Stock: Investment Sales, Financing, Advisory, Capital Markets, Leasing
Total Rating 30
Risk 94
Buy Signal -1.65
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.50% |
| Yield on Cost 5y | 1.40% |
| Yield CAGR 5y | -30.66% |
| Payout Consistency | 81.8% |
| Payout Ratio | 135.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.3% |
| Relative Tail Risk | -3.64% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.09 |
| Alpha | -41.26 |
| Character TTM | |
|---|---|
| Beta | 0.802 |
| Beta Downside | 0.859 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.53% |
| CAGR/Max DD | -0.21 |
Description: MMI Marcus & Millichap January 18, 2026
Marcus & Millichap, Inc. (NYSE: MMI) is a U.S.-based investment brokerage that facilitates the buying, selling, and financing of commercial real-estate assets across a broad spectrum of property types-including multifamily, office, industrial, retail, senior housing, self-storage, hospitality, medical office, and manufactured housing-through both brokerage and capital-markets services.
Key operational metrics that investors watch include the firm’s FY 2023 transaction volume (≈ $115 billion in gross commissions) and its diversified revenue mix: roughly 55 % from brokerage fees, 30 % from financing and capital-markets solutions, and the remainder from advisory and leasing services. The business is sensitive to macro drivers such as U.S. interest-rate trends (which affect debt-capacity and cap-rate compression) and regional vacancy rates-e.g., multifamily vacancy hovering near 5 % nationally, supporting steady demand for MMI’s advisory expertise.
For a data-rich, side-by-side performance comparison, you may find the ValueRay platform useful for digging deeper into MMI’s fundamentals.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: -6.67m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 12.01 > 1.0 |
| NWC/Revenue: 26.17% < 20% (prev 39.11%; Δ -12.93% < -1%) |
| CFO/TA 0.09 > 3% & CFO 77.0m > Net Income -6.67m |
| Net Debt (-27.8m) to EBITDA (10.1m): -2.74 < 3 |
| Current Ratio: 2.74 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.2m) vs 12m ago 1.41% < -2% |
| Gross Margin: 37.74% > 18% (prev 0.38%; Δ 3736 % > 0.5%) |
| Asset Turnover: 91.27% > 50% (prev 74.63%; Δ 16.64% > 0%) |
| Interest Coverage Ratio: -4.99 > 6 (EBITDA TTM 10.1m / Interest Expense TTM 785.0k) |
Altman Z'' 5.30
| A: 0.24 (Total Current Assets 309.8m - Total Current Liabilities 113.2m) / Total Assets 812.5m |
| B: 0.51 (Retained Earnings 415.3m / Total Assets 812.5m) |
| C: -0.00 (EBIT TTM -3.92m / Avg Total Assets 823.1m) |
| D: 1.98 (Book Value of Equity 415.5m / Total Liabilities 210.3m) |
| Altman-Z'' Score: 5.30 = AAA |
Beneish M -3.05
| DSRI: 0.82 (Receivables 41.2m/41.6m, Revenue 751.3m/622.2m) |
| GMI: 1.01 (GM 37.74% / 38.10%) |
| AQI: 1.13 (AQ_t 0.50 / AQ_t-1 0.44) |
| SGI: 1.21 (Revenue 751.3m / 622.2m) |
| TATA: -0.10 (NI -6.67m - CFO 77.0m) / TA 812.5m) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of MMI shares?
As of February 07, 2026, the stock is trading at USD 25.80 with a total of 206,569 shares traded.
Over the past week, the price has changed by -4.37%, over one month by -6.96%, over three months by -16.56% and over the past year by -30.77%.
Over the past week, the price has changed by -4.37%, over one month by -6.96%, over three months by -16.56% and over the past year by -30.77%.
Is MMI a buy, sell or hold?
Marcus & Millichap has received a consensus analysts rating of 1.00.
Therefor, it is recommend to sell MMI.
- StrongBuy: 0
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the MMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28 | 8.5% |
| Analysts Target Price | 28 | 8.5% |
| ValueRay Target Price | 24.2 | -6.2% |
MMI Fundamental Data Overview February 03, 2026
P/S = 1.4119
P/B = 1.7437
P/EG = 1.82
Revenue TTM = 751.3m USD
EBIT TTM = -3.92m USD
EBITDA TTM = 10.1m USD
Long Term Debt = 78.6m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 19.3m USD (from shortTermDebt, last quarter)
Debt = 78.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -27.8m USD (from netDebt column, last quarter)
Enterprise Value = 1.03b USD (1.06b + Debt 78.6m - CCE 106.3m)
Interest Coverage Ratio = -4.99 (Ebit TTM -3.92m / Interest Expense TTM 785.0k)
EV/FCF = 14.75x (Enterprise Value 1.03b / FCF TTM 70.0m)
FCF Yield = 6.78% (FCF TTM 70.0m / Enterprise Value 1.03b)
FCF Margin = 9.32% (FCF TTM 70.0m / Revenue TTM 751.3m)
Net Margin = -0.89% (Net Income TTM -6.67m / Revenue TTM 751.3m)
Gross Margin = 37.74% ((Revenue TTM 751.3m - Cost of Revenue TTM 467.7m) / Revenue TTM)
Gross Margin QoQ = 37.60% (prev 38.11%)
Tobins Q-Ratio = 1.27 (Enterprise Value 1.03b / Total Assets 812.5m)
Interest Expense / Debt = 0.25% (Interest Expense 197.0k / Debt 78.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -3.09m (EBIT -3.92m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.74 (Total Current Assets 309.8m / Total Current Liabilities 113.2m)
Debt / Equity = 0.13 (Debt 78.6m / totalStockholderEquity, last quarter 602.2m)
Debt / EBITDA = -2.74 (Net Debt -27.8m / EBITDA 10.1m)
Debt / FCF = -0.40 (Net Debt -27.8m / FCF TTM 70.0m)
Total Stockholder Equity = 614.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.81% (Net Income -6.67m / Total Assets 812.5m)
RoE = -1.09% (Net Income TTM -6.67m / Total Stockholder Equity 614.6m)
RoCE = -0.56% (EBIT -3.92m / Capital Employed (Equity 614.6m + L.T.Debt 78.6m))
RoIC = -0.50% (negative operating profit) (NOPAT -3.09m / Invested Capital 614.6m)
WACC = 8.27% (E(1.06b)/V(1.14b) * Re(8.87%) + D(78.6m)/V(1.14b) * Rd(0.25%) * (1-Tc(0.21)))
Discount Rate = 8.87% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.98%
[DCF Debug] Terminal Value 68.99% ; FCFF base≈70.0m ; Y1≈46.0m ; Y5≈21.0m
Fair Price DCF = 10.77 (EV 391.5m - Net Debt -27.8m = Equity 419.2m / Shares 38.9m; r=8.27% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -58.09 | EPS CAGR: -29.34% | SUE: -2.06 | # QB: 0
Revenue Correlation: -68.48 | Revenue CAGR: -22.12% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.07 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.56 | Chg30d=-0.025 | Revisions Net=+0 | Growth EPS=+420.0% | Growth Revenue=+14.8%
P/B = 1.7437
P/EG = 1.82
Revenue TTM = 751.3m USD
EBIT TTM = -3.92m USD
EBITDA TTM = 10.1m USD
Long Term Debt = 78.6m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 19.3m USD (from shortTermDebt, last quarter)
Debt = 78.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -27.8m USD (from netDebt column, last quarter)
Enterprise Value = 1.03b USD (1.06b + Debt 78.6m - CCE 106.3m)
Interest Coverage Ratio = -4.99 (Ebit TTM -3.92m / Interest Expense TTM 785.0k)
EV/FCF = 14.75x (Enterprise Value 1.03b / FCF TTM 70.0m)
FCF Yield = 6.78% (FCF TTM 70.0m / Enterprise Value 1.03b)
FCF Margin = 9.32% (FCF TTM 70.0m / Revenue TTM 751.3m)
Net Margin = -0.89% (Net Income TTM -6.67m / Revenue TTM 751.3m)
Gross Margin = 37.74% ((Revenue TTM 751.3m - Cost of Revenue TTM 467.7m) / Revenue TTM)
Gross Margin QoQ = 37.60% (prev 38.11%)
Tobins Q-Ratio = 1.27 (Enterprise Value 1.03b / Total Assets 812.5m)
Interest Expense / Debt = 0.25% (Interest Expense 197.0k / Debt 78.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -3.09m (EBIT -3.92m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.74 (Total Current Assets 309.8m / Total Current Liabilities 113.2m)
Debt / Equity = 0.13 (Debt 78.6m / totalStockholderEquity, last quarter 602.2m)
Debt / EBITDA = -2.74 (Net Debt -27.8m / EBITDA 10.1m)
Debt / FCF = -0.40 (Net Debt -27.8m / FCF TTM 70.0m)
Total Stockholder Equity = 614.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.81% (Net Income -6.67m / Total Assets 812.5m)
RoE = -1.09% (Net Income TTM -6.67m / Total Stockholder Equity 614.6m)
RoCE = -0.56% (EBIT -3.92m / Capital Employed (Equity 614.6m + L.T.Debt 78.6m))
RoIC = -0.50% (negative operating profit) (NOPAT -3.09m / Invested Capital 614.6m)
WACC = 8.27% (E(1.06b)/V(1.14b) * Re(8.87%) + D(78.6m)/V(1.14b) * Rd(0.25%) * (1-Tc(0.21)))
Discount Rate = 8.87% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.98%
[DCF Debug] Terminal Value 68.99% ; FCFF base≈70.0m ; Y1≈46.0m ; Y5≈21.0m
Fair Price DCF = 10.77 (EV 391.5m - Net Debt -27.8m = Equity 419.2m / Shares 38.9m; r=8.27% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -58.09 | EPS CAGR: -29.34% | SUE: -2.06 | # QB: 0
Revenue Correlation: -68.48 | Revenue CAGR: -22.12% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.07 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.56 | Chg30d=-0.025 | Revisions Net=+0 | Growth EPS=+420.0% | Growth Revenue=+14.8%